Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Oct 02, 2026
Why Is Seagate Technology (STX) Stock Down -14.71% Today?

Why Is Seagate Technology (STX) Stock Down -14.71% Today?

Key Takeaways

  • STX shares tumbled roughly 14.71% in Friday's session, erasing about $139 from the prior close.
  • The primary catalyst was a Nikkei report that Toshiba plans to double its hard-disk drive (HDD) production capacity for AI data centers by fiscal 2027.
  • The move raises concerns that a long stretch of tight HDD supply — and the pricing power it created — could loosen.
  • The selloff was concentrated in HDD makers; broader memory and large-cap tech indexes held up comparatively well.
  • Traders are now watching Seagate's upcoming earnings and any clarity on Toshiba's expansion timeline.

Opening Summary

Seagate Technology Holdings (STX), a leading maker of hard-disk drives and data storage solutions, saw its stock plunge on Friday after a report that rival Toshiba intends to significantly expand HDD production. The stock fell about 14.71%, closing near $806.52 versus a prior session close of $945.57. The decline was driven squarely by a supply-side competitive threat, as investors reassessed the pricing power that has powered Seagate's standout rally this year.

Catalyst: Toshiba's Plan to Double HDD Capacity

The sharp decline traces to a Nikkei Asia report that Japan's Toshiba plans to invest roughly ¥60 billion (about $380 million) to double its HDD production capacity, centered on a plant in the Philippines, targeting hard drives used in AI data centers by fiscal 2027. Toshiba is the smallest of the three major HDD manufacturers, holding just over 10% of the market by storage capacity, but has signaled a medium-term goal of reaching 30%.

The announcement matters because Seagate and its closest rival WDC have benefited enormously from constrained HDD supply amid the AI-driven data center build-out. Both companies have repeatedly highlighted tight supply as a key source of pricing leverage. A credible plan to flood the market with additional capacity directly threatens that dynamic, prompting investors to reprice Seagate's growth and margin assumptions.

Valuation and Profit-Taking After a Massive Rally

The severity of Friday's decline also reflects how far STX shares had already climbed. Coming into the session, the stock was up more than 200% year to date, leaving it sensitive to any news suggesting the industry's supply-and-demand balance could soften. With Seagate's nearline capacity already substantially allocated through 2027, investors had priced in continued scarcity and strong margins. Toshiba's expansion plan undermined a core pillar of that thesis, triggering an outsized repricing in an extended name.

Market Context and Trading Activity

The move was notably isolated to hard-drive makers. While STX and WDC fell sharply, broader memory names such as MU and SNDK held relatively steady, and large-cap technology benchmarks traded higher. This divergence confirms the selloff was a product-specific reaction rather than a broad risk-off event in the storage or semiconductor sectors. Trading volume was elevated as investors rushed to reposition, and the decline pushed shares below their 50-day moving average, a technical level watched closely by momentum traders.

What Comes Next for STX

Attention now shifts to Seagate's next earnings report, expected in late October, where investors will look for any commentary on supply, pricing, and the competitive landscape. The key uncertainty is timing: Toshiba's added capacity will not reach the market immediately, and long-term customer contracts may cushion near-term results. Still, the market will be watching for signs that the industry's tight supply-and-demand balance is loosening, as well as any response from Seagate and its peers on capacity discipline. Risks include faster-than-expected capacity additions, easing pricing, and continued profit-taking in an extended stock.

Trending AI Robots

For traders seeking a systematic edge in fast-moving markets, Tickeron's Trending AI Robots page highlights the platform's strongest-performing AI trading bots under current conditions. Tickeron offers hundreds of AI-driven bots covering thousands of tickers, varying by strategy, timeframe, performance metrics, and traded symbols. Only the most resilient performers are curated into the Trending AI Robots section, making it a useful starting point for those exploring algorithmic trading approaches.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: STX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


STX in upward trend: 10-day moving average broke above 50-day moving average on September 24, 2026

The 10-day moving average for STX crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on STX as a result. In 66 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for STX just turned positive on September 21, 2026. Looking at past instances where STX's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.

STX moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where STX advanced for three days, in 278 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 55 cases where STX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

STX broke above its upper Bollinger Band on September 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STX entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 9 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 10 (best 1 - 100 worst), indicating outstanding price growth. STX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: STX's P/B Ratio (97.087) is very high in comparison to the industry average of (7.187). P/E Ratio (66.293) is within average values for comparable stocks, (51.474). Projected Growth (PEG Ratio) (0.527) is also within normal values, averaging (23.994). Dividend Yield (0.003) settles around the average of (0.004) among similar stocks. P/S Ratio (14.706) is also within normal values, averaging (51.774).

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 31.54B. The market cap for tickers in the group ranges from -0.18 to 345.52B. DELL holds the highest valuation in this group at 345.52B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 39%. QTEX experienced the highest price growth at 124%, while XTND experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 68% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 65
Price Growth Rating: 53
SMR Rating: 80
Profit Risk Rating: 86
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
STX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a designer of data storage products

Industry ComputerProcessingHardware

Industry
Computer Peripherals
Address
121 Woodlands Avenue 5
Phone
+65 60182562
Employees
30000
Web
https://www.seagate.com
Interact to see
Advertisement
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
RH shares are down approximately 17% in premarket trading on April 1, 2026, after closing the previous session at $139.82, with the stock indicated near $115.76 — a decline of roughly $24 per share. The primary catalyst is a significant Q4 fiscal year 2025 earnings miss, with adjusted EPS of $1.53 coming in well below the Wall Street consensus of $2.22 — a 31% negative surprise.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
WDC shares surged approximately +10% in Wednesday's session, advancing to approximately $296–$297 from a prior close near $269.82 on March 31, 2026. The primary catalyst is a major analyst upgrade: Bernstein raised its rating on Western Digital from Market Perform to Outperform and dramatically doubled its price target to $340 from $170.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.